dermatology Archives -

UCB’s IL-17 latecomer bimekizumab beats Cosentyx in psoriasis trial

https://pharmaphorum.com/news/ucbs-il-17-latecomer-bimekizumab-beats-cosentyx-in-psoriasis-trial/

Novartis takes $485m hit after axing eczema drug from pipeline

https://pharmaphorum.com/news/novartis-takes-485m-hit-after-axing-eczema-drug-from-pipeline/

LEO eyeing 2021 US launch for eczema drug tralokinumab

https://pharmaphorum.com/news/leo-eyeing-2021-us-launch-for-eczema-drug-tralokinumab/

Dermatology Devices Market Size Will Achieve 11.9% CAGR From 2019 To 2025

https://pharmaphorum.com/partner-content/dermatology-devices-market-size-will-achieve-11-9-cagr-from-2019-to-2025/

Eyeing Dupixent’s territory, Leo Pharma files tralokinumab in EU

https://pharmaphorum.com/news/eyeing-dupixents-territory-leo-pharma-files-tralokinumab-in-eu/

https://pharmaphorum.com/events/hit-the-jak-pot-in-global-race-to-treat-covid-19/

Stada expands OTC business with portfolio of GSK drugs

https://pharmaphorum.com/news/stada-expands-otc-business-with-portfolio-of-gsk-drugs/

Lilly swoops on Dermira to claim Dupixent rival

https://pharmaphorum.com/news/lilly-swoops-on-dermira-to-claim-dupixent-rival/

Ligelizumab could top Xolair in chronic hives, says Novartis

https://pharmaphorum.com/news/ligelizumab-could-top-xolair-in-chronic-hives-says-novartis/

Search